| The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. | None |
| In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. | None |
| The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf. | None |
| Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. | None |
| A novel four zinc-finger protein targeted against p190(BcrAbl) fusion oncogene cDNA: utilisation of zinc-finger recognition codes. | None |
| Transformation to acute leukaemia in an MDS patient harbouring bcr-abl and bcl 2-IgH rearrangements, without expression of either activated oncogene. | None |
| The reciprocal role of Egr-1 and Sp family proteins in regulation of the PTP1B promoter in response to the p210 Bcr-Abl oncoprotein-tyrosine kinase. | None |
| Mechanisms of transformation by the BCR/ABL oncogene. | None |
| BACH2 is transcriptionally regulated by the BCR/ABL oncogene. | None |
| Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells. | None |
| Structure of the Bcr-Abl oncoprotein oligomerization domain. | None |
| Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway. | None |
| Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354. | None |
| Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein. | None |
| Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. | None |
| Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors. | None |
| Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr. | None |
| The c-Myc Oncoprotein Interacts with Bcr. | None |
| Phosphotyrosine mapping in Bcr/Abl oncoprotein using phosphotyrosine-specific immonium ion scanning. | None |
| Molecular mechanisms of transformation by the BCR-ABL oncogene. | None |